about
Retinoic acid regulates the human methionine sulfoxide reductase A (MSRA) gene via two distinct promotersRegulation of the nongenomic actions of retinoid X receptor-α by targeting the coregulator-binding sitesRegulation of stearoyl coenzyme A desaturase expression in human retinal pigment epithelial cells by retinoic acidMouse retinal dehydrogenase 4 (RALDH4), molecular cloning, cellular expression, and activity in 9-cis-retinoic acid biosynthesis in intact cellsDaily oscillation of glutathione redox cycle is dampened in the nutritional vitamin A deficiencyThe evidence for a beneficial role of vitamin A in multiple sclerosis.Indirect modulation of dopamine D2 receptors as potential pharmacotherapy for schizophrenia: III. Retinoids.RXR activators molecular signalling: involvement of a PPAR alpha-dependent pathway in the liver and kidney, evidence for an alternative pathway in the heartRetinoids: fascinating up-and-coming scenario.Identification of biomarkers regulated by rexinoids (LGD1069, LG100268 and Ro25-7386) in human breast cells using Affymetrix microarray.Tazarotene: therapeutic strategies in the treatment of psoriasis, acne and photoaging.The sodium iodide symporter (NIS): regulation and approaches to targeting for cancer therapeutics.Targeting truncated RXRα for cancer therapy.Bexarotene in the treatment of cutaneous T-cell lymphoma.Retinoic acid decreases adherence of murine myeloid dendritic cells and increases production of matrix metalloproteinase-9.Antagonizing Retinoic Acid Receptors Increases Myeloid Cell Production by Cultured Human Hematopoietic Stem Cells.Spotlight on adapalene.Efficacy and safety of topical tazarotene: a review.Oral alitretinoin: a review of the clinical pharmacokinetics and pharmacodynamics.The Molecular Mechanisms of Vitamin A Deficiency in Multiple Sclerosis.Long-term establishment, characterization and manipulation of cell lines from mouse basal cell carcinoma tumors.PI3K-AKT signaling is a downstream effector of retinoid prevention of murine basal cell carcinogenesis.Effects of retinoic acid isomers on apoptosis and enzymatic antioxidant system in human breast cancer cells.Kallikrein expression and cathelicidin processing are independently controlled in keratinocytes by calcium, vitamin D(3), and retinoic acidA novel retinoid-related molecule inhibits pancreatic cancer cell proliferation by a retinoid receptor independent mechanism via suppression of cell cycle regulatory protein function and induction of caspase-associated apoptosis.beta-Carotene stimulates chemotaxis of human endothelial progenitor cells.Vitamin A upregulates matrix metalloproteinase-9 activity by murine myeloid dendritic cells through a nonclassical transcriptional mechanism.Tretinoin peel: a critical view.Expression and Regulation of Retinoic Acid Receptor Responders in the Human Placenta.Retinoic acid improves nephrotoxic serum-induced glomerulonephritis through activation of podocyte retinoic acid receptor α.TIG1 promotes the development and progression of inflammatory breast cancer through activation of Axl kinase.Overview of the structure-based non-genomic effects of the nuclear receptor RXRα
P2860
Q24321562-3395B4B1-8660-471D-81C4-878FB4025490Q27025972-E6086217-F568-42EB-A23C-DB5BE6FA47B3Q28200956-9FD9A1AE-C504-4817-946B-E1637799FE6AQ28511745-F16AA311-1ADA-4DAB-9945-B4F82F4FD813Q28566639-D84DAFCA-1E68-4AE8-A30C-5440580EA77BQ34405797-B5CF66AD-B30A-4F81-B882-DA75AEC41D70Q34703545-36088AB6-AA78-46FC-B8D2-789E5C04B455Q35045046-E3826C0B-3041-4182-B846-32E4E9930AE0Q35139681-8FE6A335-E759-4DD3-AE8A-8C2E9D883996Q35628519-8D9FD52A-8F51-4C83-97F2-3026B0F9FDEDQ35747090-2E42AB59-72DE-4C1C-A24A-34A99339E44DQ36128415-47E601CB-6F3F-4B55-B2B8-17952C72ED99Q36398740-4E0D733D-93FA-45DA-A4E1-E097FE5A5CCFQ36458462-59313DE5-530A-4312-9BED-FD41A4D0EB6CQ36848876-0D358445-52C8-4B47-8158-FD4EF7ECAC1FQ37611247-C1A9C20E-0E8B-4A76-8070-F142FED64CBDQ37636058-9F43E2E7-364F-4011-A402-DC7FA54D03C1Q37705240-E980051E-CE81-4844-AA15-5993F6DB3A75Q38040124-B253D670-D863-42E5-9D5B-F1EBAE9003BFQ38880764-1899DF96-6D83-4207-96C2-D1EC79A6D1B9Q40249166-8B764971-64BE-4B3D-AE6C-04923E5107CEQ40355706-A7952155-8B7B-40C7-949F-FE01D81DB020Q42002274-B8757C7C-A448-48B6-B073-57100DE482ECQ42158902-D4F48924-A131-433C-81AE-70AA166192EAQ46459242-A5052ADC-EE2E-47FF-947A-2055DE27C5FEQ46495569-27CA205A-D201-475A-8F24-60645583A23EQ46530595-5D6DCACB-26C2-4662-BD5E-0183F34DC485Q47099662-11FCE9C7-6F3D-40AC-93FD-0BC2ABACE337Q49805080-48A73EB3-D08B-4EE8-99AA-20B75E7D813DQ52760701-58CA0336-7EB2-4F80-905A-F1FF15FFE585Q53090999-4496772B-63E9-4623-8511-DD0A5FF8579EQ58798014-554BAECB-EC96-49EF-85B6-6CD6E10EDF19
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Recent developments in receptor-selective retinoids.
@ast
Recent developments in receptor-selective retinoids.
@en
type
label
Recent developments in receptor-selective retinoids.
@ast
Recent developments in receptor-selective retinoids.
@en
prefLabel
Recent developments in receptor-selective retinoids.
@ast
Recent developments in receptor-selective retinoids.
@en
P356
P1476
Recent developments in receptor-selective retinoids.
@en
P2093
R A Chandraratna
P304
P356
10.2174/1381612003400146
P577
2000-06-01T00:00:00Z